Exper Perspectives Logo
  • Home
  • Therapeutic Categories
    • BACK
    • Therapeutic Categories
    • Allergy & Immunology
      • BACK
      • Allergy & Immunology
      • Chronic Spontaneous Urticaria
      • Food Allergies
      • Pediatric Food Allergies
    • Dermatology
      • BACK
      • Dermatology
      • Atopic Dermatitis
      • Plaque Psoriasis
    • Endocrinology
      • BACK
      • Endocrinology
      • Type 2 Diabetes
    • Gastroenterology
      • BACK
      • Gastroenterology
      • Crohn's Disease
      • Ulcerative Colitis
    • Hematology
      • BACK
      • Hematology
      • Chronic Immune Thrombocytopenia
      • Paroxysmal Nocturnal Hemoglobinuria
      • Sickle Cell Disease
    • Hepatology
      • BACK
      • Hepatology
      • Liver Fibrosis
    • Infectious Diseases
      • BACK
      • Infectious Diseases
      • Adolescent Vaccinations
      • Adult Vaccinations
      • Influenza
    • Nephrology
      • BACK
      • Nephrology
      • IgAN
      • IgAN & C3G
    • Neurology
      • BACK
      • Neurology
      • Alzheimer's Disease
      • Epilepsy
      • Generalized Myasthenia Gravis
      • Insomnia
      • Migraine
      • Multiple Sclerosis
      • Relapsing Multiple Sclerosis
      • Spinal Muscular Atrophy
      • Tuberous Sclerosis Complex
    • Oncology
      • BACK
      • Oncology
      • Acute Myeloid Leukemia
      • Advanced Prostate Cancer
      • Advanced ROS1-positive NSCLC
      • Anemia in MDS
      • Carcinoid Syndrome
      • Chronic Graft-versus-Host Disease
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
      • Endometrial Cancer
      • Gastroenteropancreatic Neuroendocrine Tumors
      • Gastrointestinal Stromal Tumors
      • HER2+ Breast Cancer
      • HR+ HER2- Breast Cancer
      • HR+/HER2- Early Breast Cancer
      • Locally Advanced Basal Cell Carcinoma
      • Mantle Cell Lymphoma
      • Melanoma
      • Metastatic Breast Cancer
      • Metastatic Pancreatic Cancer
      • Multiple Myeloma
      • Myelofibrosis
      • Myeloproliferative Neoplasms
      • Non-Small Cell Lung Cancer
      • Prostate Cancer
      • PSMA+ mCRPC
      • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
      • Relapsed/Refractory Multiple Myeloma
    • Ophthalmology
      • BACK
      • Ophthalmology
      • Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    • Osteoporosis
      • BACK
      • Osteoporosis
      • Osteoporosis
    • Psychiatry
      • BACK
      • Psychiatry
      • Major Depressive Disorder
      • Schizophrenia
      • Tardive Dyskinesia
    • Pulmonology
      • BACK
      • Pulmonology
      • Asthma
      • Chronic Obstructive Pulmonary Disease
      • Interstitial Lung Disease
    • Rheumatology
      • BACK
      • Rheumatology
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
  • Conference Reporter
  • Expert Directory
  • About Expert Perspectives
  • Login/Register

experspadmin

Updated Osteoporosis Treatment Recommendations Begin Consensus Building
Osteoporosis

Updated Osteoporosis Treatment Recommendations Begin Consensus Building

clinical topic updates
By Tom Iarocci, MD
In a Perfect World, Could Targeted Therapy Eliminate the Use of Corticosteroids in Rheumatoid Arthritis?
Rheumatology

In a Perfect World, Could Targeted Therapy Eliminate the Use of Corticosteroids in Rheumatoid Arthritis?

expert roundtables
By Jeffrey R. Curtis, MD, MS, MPH; Jonathan Kay, MD; Leonard H. Calabrese, DO
Treatment-Resistant Rheumatoid Arthritis: An Unmet Need
Rheumatology

Treatment-Resistant Rheumatoid Arthritis: An Unmet Need

expert roundtables
By Jeffrey R. Curtis, MD, MS, MPH; Jonathan Kay, MD; Leonard H. Calabrese, DO
Management of Unacceptable Pain or Refractory Pain in Patients Who Have Inadequate Responses to Disease-Modifying Antirheumatic Drugs
Rheumatology

Management of Unacceptable Pain or Refractory Pain in Patients Who Have Inadequate Responses to Disease-Modifying Antirheumatic Drugs

patient care perspectives
By Jeffrey R. Curtis, MD, MS, MPH
Venous Thromboembolism Risk From Higher Doses of Janus Kinase Inhibitors
Rheumatology

Venous Thromboembolism Risk From Higher Doses of Janus Kinase Inhibitors

clinical topic updates
By Jonathan Kay, MD
Load More   
logo 2026 Expert Perspectives®
Privacy Policy     Terms of Service     About Expert Perspectives

Your California Privacy Rights     Do Not Sell My Personal Information
Login Expert Perspectives
Forgot Password?
or Create an Account
Create an Account
Forgot Password?